Combines Molecular Spectroscopy Techniques with Analytical Chemistry Expertise to Uncover Nutritional Value of Food WALTHAM, Mass--PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with TeakOrigin, a company that integrates technology and data platforms to serve as a detector for food authenticity and quality. PerkinElmer’s cutting-edge molecular spectroscopy instrumentation, [...]

Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and [...]

SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges [...]

IPSWICH, Mass. and VILNIUS, Lithuania -- New England Biolabs, Inc. (NEB®) and CasZyme, a recently-formed startup company based in Vilnius, Lithuania, announced today that they have entered into a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases, with the goal of providing researchers with additional tools for genome editing and molecular biology applications. Under the terms of the agreement, [...]

Location: Cambridge First-to-market cfDNA Reference Standard specific for EGFR gene mutations adds to Horizon’s existing portfolio of cfDNA controls Horizon’s EGFR Multiplex cfDNA Reference Standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays Covers EGFR mutations implicated in the responsiveness to EGFR tyrosine kinase inhibitors and [...]

Our distributor agreement with BIOZOL expands the availability of the Novallele™ genotyping and copy number assays MELVILLE, N.Y. Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a new distributor, BIOZOL Diagnostica Vertrieb GmbH, that will distribute all of the Novallele [...]

Shimadzu Corporation, Fujitsu Limited, and Fujitsu Laboratories Ltd. are undertaking collaborative research*1to develop technology that utilizes AI (artificial intelligence) to process the vast amounts of data used in analyzing the measurement results, which are essential to analytical processes, acquired from Shimadzu mass spectrometers. Fujitsu, an information and communication technology company, has been exploring the creation [...]

Base4 is celebrating the grant of DNA sequencing patent US 9,771,615. This is our 8th granted patent family and our 25th granted patent, 22 of which have been granted over the past 3 years. Base4 is an IP rich company and our continued success underlines the degree to which our approach is novel and highly [...]

Showa Denko (SDK) (TOKYO: 4004) decided at its board meeting today on changes in corporate management. Akiyoshi Morita will resign as Outside Director at the General Meeting of Shareholders in late March 2018. Kiyoshi Nishioka (Adviser, Research Center for Advanced Science and Technology, The University of Tokyo) will be elected Director at the same General [...]

This year’s Simcyp Simulator enhancements include new oncology and preterm-birth populations, enhanced skin and gut transporter models, and additional regulatory qualification summaries PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator. “We are proud to introduce several significant advances [...]